HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Additive Effect of Topical Nepafenac on Mydriasis in Patients With Diabetes Mellitus.

AbstractOBJECTIVES:
To evaluate the additive effect of topical nepafenac on pupil diameter (PD) in patients with diabetes mellitus (DM) and cataract.
METHODS:
This prospective comparative study included the patients having cataract surgery with and without DM. Two consecutive PD measurements were taken using an automatic quantitative pupillometry system (MonPack One, Metrovision). A baseline measurement was taken, then one drop of nepafenac % 0.1 (Nevanac; Alcon, Fort Worth, TX) was instilled only to the eye that will be operated on (study eye). Cyclopentolate 1.0% (Sikloplejin; Abdi İbrahim, İstanbul, Turkey) was instilled to both eyes (study eye/fellow eye) 5 minutes later. The second measurement was taken at 1 hour after this application.
RESULTS:
The DM group consisted of 43 patients, and the control group consisted of 39 participants. The baseline PDs of both eyes were similar in the DM group (P=0.070) and the control group (P=0.345). The change in pupil size from baseline to mydriasis was statistically significantly greater in the study eyes (2.69±0.53) than fellow eyes (2.54±0.61) in the DM group (P=0.009), but there was no statistically significant difference in the control group (2.94±0.63 vs. 2.86±0.58). When the groups were compared, the PD changes were similar in the study eyes between groups (P=0.065), while the PD changes in the fellow eyes were lower in the DM group (P=0.017).
CONCLUSIONS:
Nepafenac has been shown additive effect on pupil dilation in diabetic patients before cataract surgery.
AuthorsHasan Kiziltoprak, Mustafa Koc, Esat Yetkin, Kemal Tekin, Merve Inanc, Kemal Ozulken
JournalEye & contact lens (Eye Contact Lens) Vol. 46 Issue 5 Pg. 310-313 (Sep 2020) ISSN: 1542-233X [Electronic] United States
PMID31503086 (Publication Type: Journal Article)
Chemical References
  • Benzeneacetamides
  • Phenylacetates
  • nepafenac
Topics
  • Benzeneacetamides
  • Diabetes Mellitus
  • Humans
  • Mydriasis
  • Phenylacetates
  • Prospective Studies
  • Pupil

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: